1. Home
  2. OSPN vs LRMR Comparison

OSPN vs LRMR Comparison

Compare OSPN & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

N/A

Current Price

$17.83

Market Cap

561.7M

Sector

Technology

ML Signal

N/A

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

N/A

Current Price

$3.91

Market Cap

455.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSPN
LRMR
Founded
1991
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.7M
455.8M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
OSPN
LRMR
Price
$17.83
$3.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.67
$16.50
AVG Volume (30 Days)
312.9K
858.0K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
4.53%
N/A
EPS Growth
28.77
N/A
EPS
0.48
N/A
Revenue
$243,180,000.00
N/A
Revenue This Year
$3.22
N/A
Revenue Next Year
$3.16
$1,816.14
P/E Ratio
$35.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.07
$2.72
52 Week High
$18.48
$6.42

Technical Indicators

Market Signals
Indicator
OSPN
LRMR
Relative Strength Index (RSI) 66.08 43.68
Support Level $14.86 $3.57
Resistance Level $18.48 $4.21
Average True Range (ATR) 0.48 0.19
MACD 0.08 -0.03
Stochastic Oscillator 90.77 11.65

Price Performance

Historical Comparison
OSPN
LRMR

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: